⏳
Showing Q4 2023 data
Autonomy Capital (Jersey) L.P.'s Q4 2025 filing not yet available. Expected by Feb 14, 2026.
Autonomy Capital (Jersey) L.P.
•CIK: 1484153•Filing: Q4 2023
**Autonomy Capital (Jersey) L.P.** manages $55M across a concentrated portfolio of 14 positions. The fund exhibits significant conviction in key technology and biotech names, with top holdings including MRNA ($8.6M) and TSLA ($8.2M). Notable allocations also include PAM ($7.5M) and ASML ($7.2M), suggesting a focus on disruptive growth sectors. This structure indicates a tactical, high-conviction approach to capital deployment.
Total AUM
$52.6M
QoQ Performance
N/A
Positions
13
Top 10 Concentration
99.2%
Latest Filing
Q4 2023
Top Holdings Allocation
MRNA
TSLA
PAM
ASML
CEPU
DIDIY
STEM
NEE
MRNA16.3%
TSLA15.5%
PAM14.3%
ASML13.7%
CEPU13.3%
DIDIY7.4%
STEM7.1%
NEE5.3%
📈 Biggest Buys
📉 Biggest Sells
No reductions this quarter
Sector Breakdown
Other79.2%
Consumer15.5%
Utilities5.3%